Enliven Therapeutics

Boulder, United States

Enliven Therapeutics is a precision oncology company developing small molecule therapies to extend and improve patient lives.

Jun 2026

Post-IPO Equity

Biotechnology Life Science Oncology Therapeutics

Top Investors

Cormorant Asset ManagementJanus Henderson InvestorsOrbiMedCommodore Capital5AM Ventures

Founder Contacts

19,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Enliven Therapeutics

Who are Enliven Therapeutics's investors?

Enliven Therapeutics's investors include Cormorant Asset Management, Janus Henderson Investors, OrbiMed, Commodore Capital, 5AM Ventures.

Where is Enliven Therapeutics headquartered?

Enliven Therapeutics is headquartered in Boulder, United States.

What does Enliven Therapeutics do?

Enliven Therapeutics is a precision oncology company developing small molecule therapies to extend and improve patient lives.

What stage is Enliven Therapeutics at?

Enliven Therapeutics is at the Post-IPO Equity stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated June 11, 2026.

MLA

"Enliven Therapeutics — Funding & Investors." VCBacked, June 11, 2026, https://www.vcbacked.co/company/enliven-therapeutics. Accessed June 30, 2026.

APA

VCBacked. (2026). Enliven Therapeutics — Funding & Investors. Retrieved June 30, 2026, from https://www.vcbacked.co/company/enliven-therapeutics

Wikipedia (cite web)

{{cite web |title=Enliven Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/enliven-therapeutics |website=VCBacked |access-date=June 30, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated June 11, 2026.

Similar Companies in Biotechnology